Prognosis
Fauci Optimistic for New Covid Treatment to Be Available by Fall
- Monoclonal antibodies are currently in clinical trial phase
- U.S. needs ‘time out’ to tackle virus, Fauci tells Zuckerberg
This article is for subscribers only.
Anthony Fauci told Facebook, Inc. ‘s Mark Zuckerberg that he expects results for a clinical trial on monoclonal antibodies by late summer or early fall, underscoring the speed at which the government has been working to quickly approve and roll out treatment for the novel coronavirus.
A monoclonal antibody is a laboratory-produced protein that can potentially be used to treat sick patients as well as for prophylaxis. Fauci, the top U.S. infectious disease expert, described them as “precise bullets” that can be developed from antibodies from other people who’ve been infected and used as a treatment to fight the virus at multiple stages.